Tandem Diabetes Care
TNDM
TNDM
184 hedge funds and large institutions have $1.77B invested in Tandem Diabetes Care in 2018 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 57 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
46% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 39
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
5.45% more ownership
Funds ownership: 66.7% → 72.15% (+5.5%)
Holders
184
Holding in Top 10
7
Calls
$91.9M
Puts
$40.1M
Top Buyers
| 1 | +$80.7M | |
| 2 | +$60M | |
| 3 | +$46.8M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$45.8M |
| 5 |
BlackRock
New York
|
+$41.7M |
Top Sellers
| 1 | -$98.1M | |
| 2 | -$70.3M | |
| 3 | -$50.4M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$44.9M |
| 5 |
O
OrbiMed
New York
|
-$41.7M |